human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 1 2
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Parkinson's Disease | 2 |
| Parkinson Disease (PD) | 1 |
Recruiting trials involving human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection
- Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
- The Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
Common questions
How many recruiting trials involve human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection?
2 recruiting trials across 2 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.